Submission Details
| 510(k) Number | K231982 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 05, 2023 |
| Decision Date | September 12, 2024 |
| Days to Decision | 435 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K231982 is an FDA 510(k) clearance for the Quantum Perfusion Blood Oxygenator VT75-E1, Quantum Perfusion Blood Oxygenator VT75-E2, a Oxygenator, Cardiopulmonary Bypass (Class II — Special Controls, product code DTZ), submitted by Qura S.R.L (Mirandola, IT). The FDA issued a Cleared decision on September 12, 2024, 435 days after receiving the submission on July 5, 2023. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.4350.
| 510(k) Number | K231982 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 05, 2023 |
| Decision Date | September 12, 2024 |
| Days to Decision | 435 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DTZ — Oxygenator, Cardiopulmonary Bypass |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.4350 |